Three weeks after a concert last year, I noticed the ringing in my left ear had stopped being constant and dropped to occasional. That experience sent me into the research on why tinnitus persists in some people and resolves in others, and the neuroscience behind tinnitus causes is far more interesting than I expected.Ringing in the ears is the most common form of tinnitus, but the experience is broader than that: buzzing, hissing, roaring, clicking.

The unifying feature is that the sound has no external source. What drives it isn’t a sound entering your ear. It’s a change in how your auditory nervous system generates and amplifies internal signals. Knowing which tinnitus causes are at work changes what you do about it.

What is tinnitus: types, prevalence, and the mechanism

Quick Answer: Tinnitus affects about 50 million Americans, roughly 15% of the adult population. In 99% of cases it is subjective (only the affected person can hear it). Objective tinnitus (audible to an examiner using a stethoscope) accounts for under 1% of cases and usually points to a vascular or muscular source. The mechanism of subjective tinnitus: outer hair cell damage reduces auditory input to the central auditory cortex, which responds by increasing central gain, amplifying background neural noise, and producing phantom sound. Most tinnitus causes trace back to this central gain shift.

Subjective tinnitus (99% of cases): Only the person experiencing it can hear it. The sound is generated within the auditory nervous system, not from an external or mechanical source. Subjective tinnitus can be tonal (a specific pitch or narrow-band tone) or noise-like (broadband hiss, roar, static). It can be unilateral (one ear), bilateral (both ears), or perceived as “inside the head.” The AAO-HNS Clinical Practice Guideline defines clinically significant tinnitus as tinnitus lasting more than 6 months that bothers the patient.

Objective tinnitus (<1% of cases): The sound is mechanically produced and audible to an examiner. Common sources: vascular turbulence (arteriovenous malformations, carotid artery stenosis, high-output cardiac states like anemia or pregnancy), muscular contractions (tensor tympani syndrome, palatal myoclonus), or Eustachian tube clicks. These mechanical tinnitus causes are often pulsatile and need imaging for diagnosis.

The central gain mechanism: When outer hair cells are damaged by noise, aging, or ototoxic medication, they reduce the electrical input they send to the auditory brainstem. The brain responds to this reduced input by increasing amplification, raising its own internal “gain.” This increased central gain amplifies spontaneous neural firing within the auditory cortex, producing phantom sound. This is why tinnitus correlates so strongly with hearing loss, and why interventions that increase auditory input (hearing aids, sound enrichment) can reduce tinnitus loudness. These upstream tinnitus causes are why restoring input often helps.

About 90% of tinnitus cases come with at least some degree of hearing loss on audiometry, according to data from the 2016 JAMA Otolaryngology epidemiological survey (Bhatt et al., N=75,764). Of the 10% with apparently normal hearing, many have hidden hearing loss, one of the subtler tinnitus causes, with damage to inner hair cell synapses that doesn’t show up on standard pure-tone audiometry.

Tinnitus causes: noise exposure and medical conditions

Quick Answer: The main tinnitus causes start with noise-induced hearing loss, the most common one (about 90 million Americans have some noise-related hearing damage). Age-related hearing loss (presbycusis), ototoxic medications, earwax impaction, and otosclerosis are the next most common. Less frequent tinnitus causes include Meniere’s disease, acoustic neuroma, thyroid disease, hypertension, TMJ disorders, and head or neck injuries. Each of these tinnitus causes has a distinct mechanism and management approach.

1. Noise-induced hearing loss (NIHL), the most common The NIOSH standard: 85 dB is the exposure limit for an 8-hour workday without hearing protection. Every 3 dB increase halves the safe exposure time (88 dB drops it to 4 hours, 91 dB to 2 hours, 94 dB to 1 hour, 100 dB to 15 minutes). A live concert averages 100 to 110 dB. A motorcycle: 95 dB. A power drill: 98 dB. Repeated exposures above 85 dB without protection cause permanent outer hair cell stereocilia damage. It’s cumulative, irreversible, and one of the tinnitus causes that announces itself years before noticeable hearing loss.

2. Age-related hearing loss (presbycusis) Bilateral high-frequency hearing loss beginning in the 3 to 8 kHz range, progressive with age, affecting more than 50% of adults over 75. Tinnitus frequently accompanies presbycusis, usually matching the frequency region of greatest loss. Like most tinnitus causes, the mechanism is the same central gain model: reduced input drives phantom sound.

3. Ototoxic medications Several classes of medications sit among the tinnitus causes by damaging cochlear hair cells:

• Aminoglycoside antibiotics (Rx): gentamicin, streptomycin, tobramycin. Primarily target outer hair cells; irreversible damage; audiological monitoring recommended during treatment
• Platinum-based chemotherapy (Rx): cisplatin, carboplatin. Dose-dependent cochlear toxicity; tinnitus and high-frequency hearing loss in 40 to 80% of patients
• Loop diuretics (Rx): furosemide, ethacrynic acid. Generally reversible at standard doses; risk rises with high doses or IV administration
• High-dose aspirin (>6 to 8 tablets/day): reversible tinnitus and hearing loss at very high doses; resolves with dose reduction
• Quinine and antimalarials (Rx): reversible ototoxicity at therapeutic doses; more pronounced at higher doses

The signs of magnesium deficiency article is relevant here. Magnesium has been studied as a protective agent against cisplatin and noise-induced ototoxicity, since it modulates NMDA receptor excitotoxicity in the cochlea. These drug-related tinnitus causes are partly avoidable with monitoring.

4. Medical conditions among the tinnitus causes:

• Earwax impaction: the most reversible cause. Removal usually resolves the tinnitus
• Ear infections (otitis media/externa): resolves with treatment
• Otosclerosis: abnormal bone growth in the middle ear; tinnitus tied to conductive hearing loss
• Meniere’s disease: episodic tinnitus (often low-frequency roar) with vertigo, fluctuating hearing loss, and ear fullness, the classic tetrad
• Acoustic neuroma (vestibular schwannoma): benign tumor on the CN VIII nerve, usually unilateral; unilateral tinnitus with or without hearing loss warrants MRI
• Hypertension, hypothyroidism, anemia: systemic conditions that increase vascular turbulence or reduce oxygen delivery; treating the underlying condition can improve tinnitus
• TMJ disorders and cervical spine pathology: somatic tinnitus, where the sound is modulated by jaw or neck movements, a distinctive feature from audiological tinnitus

Pulsatile tinnitus: when to seek immediate medical evaluation

Quick Answer: Pulsatile tinnitus, a rhythmic sound synchronous with the heartbeat, is distinct from tonal or noise-like tinnitus and needs a different diagnostic approach. Most commonly it sounds like “whooshing” or “throbbing.” Some cases are benign (high cardiac output states, superior semicircular canal dehiscence), but pulsatile tinnitus can signal vascular pathology including sigmoid sinus diverticulum, dural arteriovenous fistula, paraganglioma (glomus tumor), or carotid artery disease. New-onset unilateral pulsatile tinnitus needs MRI/MRA. These vascular tinnitus causes need ruling out fast.

⚠️ Seek urgent medical evaluation if you have:

• New-onset pulsatile tinnitus (especially unilateral, new in recent weeks)
• Pulsatile tinnitus with severe headache and visual changes (possible idiopathic intracranial hypertension, also called pseudotumor cerebri)
• Pulsatile tinnitus that seems to worsen when you press lightly on the jugular vein (possible venous sinus pathology)
• Any tinnitus with sudden hearing loss (within 72 hours; sudden sensorineural hearing loss is treated as a medical emergency requiring high-dose corticosteroids within days)
• Unilateral tinnitus with facial numbness, weakness, or balance problems (possible acoustic neuroma or other CN VIII lesion)
• Unilateral tinnitus with ear fullness and vertigo (possible Meniere’s disease requiring formal vestibular evaluation)

The distinction matters because the workup for pulsatile tinnitus, CT angiography or MRA of the head and neck, is different from the audiogram and MRI used for non-pulsatile tinnitus. Missing a sigmoid sinus diverticulum or dural AV fistula means missing one of the correctable tinnitus causes, and in rare cases, a lesion with vascular risk.

Tinnitus diagnosis: what an audiologist actually tests

Quick Answer: Tinnitus and hearing loss assessment starts with a pure tone audiogram (250 to 8000 Hz, extended to 16,000 Hz for early NIHL detection), tympanometry, speech discrimination scores, and tinnitus-specific measures: pitch matching, loudness matching (most tinnitus is matched at 5 to 10 dB SL, far quieter than it feels), minimum masking level, and residual inhibition. The Tinnitus Handicap Inventory (THI) is a validated 25-item questionnaire scored from 0 to 100 that measures psychological distress severity. The workup also screens for the tinnitus causes that need imaging.

The audiogram: Pure tone air and bone conduction across 250 to 8000 Hz establishes hearing thresholds. Most audiologists extend to 10,000 to 16,000 Hz for tinnitus patients to capture the high-frequency notch typical of noise-induced hearing loss (usually at 4 kHz). The notch location often corresponds to the perceived tinnitus pitch.

Tinnitus-specific measures:

• Pitch matching: the patient selects which comparison tone best matches the tinnitus sound. Most tinnitus matches tones in the 3 to 8 kHz range.
• Loudness matching: shows how loud the tinnitus is relative to threshold. Usually 5 to 10 dB above threshold (very quiet acoustically, which explains why the subjective loudness is out of proportion to objective measurement).
• Minimum masking level (MML): the lowest level of broadband noise that masks the tinnitus. Used for sound therapy calibration.
• Residual inhibition: after masking, does the tinnitus reduce in perceived loudness temporarily? Positive residual inhibition predicts a better response to sound therapy.

Tinnitus Handicap Inventory (THI): A validated 25-item questionnaire producing a score from 0 to 100 across three subscales (functional, emotional, catastrophic). Scores: 0 to 16 = slight; 18 to 36 = mild; 38 to 56 = moderate; 58 to 76 = severe; 78 to 100 = catastrophic. THI is used both for baseline assessment and to track treatment response. Meaningful clinical improvement is defined as a 20-point reduction on the THI, the threshold used in the Cima 2012 Lancet trial.

When imaging is indicated: To catch the structural tinnitus causes, MRI with gadolinium contrast is recommended for: unilateral tinnitus (to rule out acoustic neuroma), sudden sensorineural hearing loss, and pulsatile tinnitus. CT temporal bone for suspected otosclerosis or middle ear pathology. CT angiography or MRA for pulsatile tinnitus with suspected vascular cause.

Tinnitus treatment: what the evidence actually shows

Quick Answer: The tinnitus treatment with the strongest evidence base is cognitive behavioral therapy (CBT), the only intervention shown to reduce tinnitus-related distress in a rigorous large-scale randomized controlled trial (Cima 2012 Lancet, N=492). Sound-based therapies (masking, tinnitus retraining therapy) reduce awareness. Hearing aids clearly help people with concurrent hearing loss, one of the most treatable tinnitus causes. The AAO-HNS 2014 Clinical Practice Guideline recommends CBT and sound therapy, and explicitly recommends against routine pharmacotherapy, dietary supplements, and Ginkgo biloba.

Cognitive behavioral therapy (CBT), first-line The Cima et al. 2012 Lancet study (N=492) is the key RCT for tinnitus CBT. Patients randomized to specialized CBT showed larger THI reductions than usual care (12.1 vs 4.3 points at 12 months), with effects maintained at follow-up. CBT doesn’t reduce the loudness of tinnitus. It reduces the distress tinnitus causes.The mechanism explains why: tinnitus distress comes mainly from the cognitive appraisal of the sound (“this is ruining my life,” “I’ll never sleep again”) and from hypervigilance, the brain’s attentional system trained to monitor the sound constantly.

Two people with identical tinnitus can have wildly different distress depending on these cognitive factors. CBT targets the appraisals (cognitive restructuring) and the attentional patterns (attention training and acceptance-based components) rather than the signal itself. Acceptance and Commitment Therapy (ACT) is an emerging alternative with good preliminary evidence.

Tinnitus retraining therapy (TRT) TRT combines directive counseling (explaining the neurophysiological model of tinnitus) with low-level broadband sound therapy worn for 6 to 8 hours a day. The goal is neural habituation, gradually reducing the brain’s attentional response to tinnitus by pairing it with neutral rather than aversive associations. Unlike masking, which aims to suppress awareness, TRT aims to make the brain treat tinnitus as a neutral background signal over 12 to 24 months.

Tinnitus masking and sound therapy White noise devices, bedside sound machines, and hearing aids with masking features use broadband noise or nature sounds to raise the auditory “floor,” reducing the perceptual contrast between silence and tinnitus. Masking provides immediate relief during use but doesn’t produce long-term habituation on its own, and it doesn’t touch the underlying tinnitus causes. Notched music therapy (removing the frequency band matching tinnitus pitch) has preliminary evidence for long-term loudness reduction through auditory cortex reorganization.

Hearing aids For the roughly 90% of tinnitus patients with underlying hearing loss, hearing aids address both conditions at once: amplifying ambient sound increases auditory input, which reduces central gain and reduces tinnitus loudness. The AAO-HNS 2014 Clinical Practice Guideline (Tunkel et al.) strongly recommends audiological evaluation for tinnitus patients specifically to identify and address concurrent hearing loss. Many people resist hearing aids even when indicated, which means they keep maintaining the central gain mechanism driving their tinnitus.

Treating hearing loss removes one of the most common tinnitus causes from the equation.The how to fall asleep faster article covers sleep with tinnitus: the quiet bedroom that’s ideal for sleep removes the auditory input that reduces tinnitus contrast, making it more intrusive. Sound enrichment at night (white noise, pink noise, nature sounds just below the tinnitus masking level) is the practical bridge between sleep hygiene and tinnitus management.

Medications and supplements for tinnitus: what the evidence shows

Quick Answer: No FDA-approved medication specifically targets tinnitus. Off-label medications are sometimes used for comorbid conditions that worsen tinnitus distress (antidepressants for concurrent depression or anxiety, short-term benzodiazepines for acute crisis). The AAO-HNS 2014 Clinical Practice Guideline explicitly recommends against antidepressants, anticonvulsants, dietary supplements, and Ginkgo biloba for routine management: the evidence does not support their use as primary tinnitus treatments.

What has no reliable evidence:Ginkgo biloba: The most studied supplement for tinnitus. Four Cochrane systematic reviews and the AAO-HNS guideline reach the same conclusion: no benefit over placebo. Widely marketed, not evidence-based.Zinc: One small positive trial in zinc-deficient populations. In zinc-replete individuals, no benefit. Only relevant if blood zinc is actually low.Melatonin: May improve sleep quality in tinnitus patients (tinnitus makes sleep initiation harder, and melatonin aids sleep onset).

This is a secondary effect on sleep, not a direct tinnitus treatment. If you’re using melatonin for tinnitus-related sleep disruption, a low dose of 0.5 to 1mg as a chronobiotic (taken 5 to 6 hours before bedtime) is the evidence-based approach. The sleep article covers this.Betahistine: Commonly used for Meniere’s disease in Europe. No reliable evidence for idiopathic tinnitus.

Off-label pharmacotherapy (Rx), for comorbid conditions only:

• Antidepressants (nortriptyline, paroxetine Rx): not for tinnitus directly, but for concurrent depression or anxiety that amplifies tinnitus distress. The anxiety-tinnitus cycle is real: anxiety increases attentional focus on the tinnitus, which increases distress, which increases anxiety, and the distress tinnitus causes compounds it. Breaking the anxiety component can reduce tinnitus handicap even without changing the sound.
• Benzodiazepines (Rx): short-term only for acute crisis. Not recommended for chronic tinnitus management, given dependence risk, and withdrawal from benzodiazepines can itself become one of the temporary tinnitus causes.
• Lidocaine IV (Rx): shown to suppress tinnitus temporarily in research settings. Not clinically practical.

The stress reduction article and how to stop overthinking guide are directly relevant to the anxiety-tinnitus cycle. Both physiological stress reduction (lowering autonomic arousal) and cognitive approaches (reducing rumination and hypervigilance) are components of comprehensive tinnitus relief programs. They target the distress tinnitus causes rather than the signal.

Protecting your hearing and preventing tinnitus

Quick Answer: The most effective approach is to prevent tinnitus: once outer hair cells are damaged by noise or ototoxic medication, they do not regenerate in humans. The 85 dB / 8-hour rule (NIOSH standard) is the threshold. Above 85 dB, time limits apply. Every 3 dB above 85 dB halves safe exposure duration. A live concert at 105 dB exceeds the safe exposure limit in about 1 minute without protection. Loud noise is one of the few tinnitus causes you can fully control.

Noise exposure limits (NIOSH standard):

Ear protection options:

• Standard foam earplugs: 29 to 33 dB NRR (noise reduction rating). Effective but muffle sound quality
• High-fidelity or musician earplugs (Etymotic, EarPeace, Loop): 15 to 22 dB NRR. Reduce overall level while preserving frequency balance. Much better for music events, since you can still hear conversations and music clearly, just at a safer level.
• Earmuffs: 25 to 30 dB NRR. Effective for power tools and industrial settings, blunting the loudest tinnitus causes at the source

Headphone listening: The WHO recommends the 60/60 rule as a starting point: 60% of maximum volume for up to 60 minutes at a time. More practically: if someone next to you can hear your headphones, the volume is too high. Volume is among the tinnitus causes you manage daily. Noise-canceling headphones let you listen at lower volume by reducing background noise, which is better for hearing health than in-ear earbuds competing with the environment.

Ototoxic medication monitoring: If you’re starting aminoglycoside antibiotics or cisplatin chemotherapy, ask your prescribing physician about baseline audiological evaluation and monitoring. Early detection of ototoxic hearing changes allows dose adjustment in some treatment protocols, heading off one of the avoidable tinnitus causes. The anti-inflammatory foods article covers dietary patterns linked to reduced inflammatory damage, relevant for maintaining cochlear health in the context of systemic inflammation.

Living with tinnitus: habituation and long-term management

Quick Answer: Habituation, the brain’s natural process of deprioritizing persistent, non-threatening stimuli, happens spontaneously in many tinnitus patients over months to years. The factors that speed up habituation: reducing the emotional significance attached to the tinnitus sound (CBT addresses this directly), keeping sound enrichment in quiet environments (which stops the brain from focusing on tinnitus in silence), continuing daily life without restriction, and avoiding the “checking” habit of repeatedly monitoring whether the tinnitus is there, which reinforces attentional priority.

Tinnitus loudness, as objectively measured, rarely decreases over time after the first year. In people who successfully manage tinnitus, the signal doesn’t change. The response does: the brain deprioritizes it from conscious attention, the way background air-conditioning noise fades after a few minutes in a new environment. This isn’t suppression. It’s a real reprocessing of the stimulus.The factors that impede habituation are worth understanding. Sleep deprivation ranks among the everyday tinnitus causes of worse symptoms, both in perceived loudness and in distress ratings.

The cortisol elevation from poor sleep increases central gain in auditory processing. Anxiety (which most tinnitus patients develop, understandably) increases vigilance toward the sound. Each moment of checking whether the tinnitus is there today reinforces the brain’s surveillance of that signal. Cognitive behavioral approaches directly target these amplification cycles. They don’t erase the tinnitus causes, but they quiet the response.

Frequently asked questions about tinnitus

This article provides general educational health information about tinnitus. It is not a substitute for professional medical advice, diagnosis, or treatment. Persistent tinnitus, especially new-onset unilateral tinnitus, pulsatile tinnitus, or tinnitus accompanied by sudden hearing loss or vertigo, warrants evaluation by an audiologist or ENT physician. If you experience sudden hearing loss with tinnitus, seek emergency medical care within 72 hours, as treatment with corticosteroids is time-sensitive. Medications mentioned (aminoglycosides, cisplatin, furosemide, benzodiazepines, antidepressants) require prescription from a licensed healthcare provider.